Cargando…

Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis

BACKGROUND: The HAS-BLED and ORBIT scores have been proposed to assess bleeding risk in anticoagulated atrial fibrillation patients. We performed a systematic review and meta-analysis to compare the predictive ability by using these two scores. MATERIALS AND METHODS: We searched the Cochrane Library...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Cen, Yu, Ye, Zhu, Wengen, Yu, Jianhua, Lip, Gregory Y.H., Hong, Kui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752553/ https://www.ncbi.nlm.nih.gov/pubmed/29312640 http://dx.doi.org/10.18632/oncotarget.19858

Ejemplares similares

Revised HAS‐BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants
por: Methavigul, Komsing
Publicado: (2022)

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
por: Proietti, Marco, et al.
Publicado: (2018)

Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis
por: Zhu, Wengen, et al.
Publicado: (2017)

HAS-BLED vs. ORBIT scores in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis
por: Liu, Xuyang, et al.
Publicado: (2023)

Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Gao, Xinxing, et al.
Publicado: (2021)

Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation: A PRISMA-compliant article
por: Zeng, Junquan, et al.
Publicado: (2020)

Use of simplified HAS‐BLED score in patients with atrial fibrillation receiving warfarin
por: Methavigul, Komsing, et al.
Publicado: (2019)

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
por: Brown, Joshua D., et al.
Publicado: (2018)

Mortality Prediction of the CHA(2)DS(2)-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation
por: Morrone, Doralisa, et al.
Publicado: (2020)

Performance of the HAS‐BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database
por: Pastori, Daniele, et al.
Publicado: (2022)

Incremental Value of Genotype Bins over the HAS-BLED Score for the Prediction of Bleeding Risk in Warfarin-Treated Patients with Atrial Fibrillation
por: Liu, Jia, et al.
Publicado: (2021)

Direct oral anticoagulation in atrial fibrillation and heart valve surgery—a meta-analysis and systematic review
por: Gerfer, Stephen, et al.
Publicado: (2022)

Relation of red cell distribution width with HAS-BLED score in patients with non-valvular atrial fibrillation
por: Cai, Hong-Li, et al.
Publicado: (2021)

Prophylactic Atrial Fibrillation Ablation in Atrial Flutter Patients without Atrial Fibrillation: A Meta-Analysis with Trial Sequential Analysis
por: Xie, Xinxing, et al.
Publicado: (2018)

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment
por: Kooiman, Judith, et al.
Publicado: (2015)

HAS-BLED Score for Prediction of Bleeding and Mortality After Transcatheter Aortic Valve Replacement
por: Albabtain, Monirah A., et al.
Publicado: (2023)

Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
por: Joosten, Linda P T, et al.
Publicado: (2023)

Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies
por: Chan, Yi-Hsin, et al.
Publicado: (2023)

Liver transplantation and atrial fibrillation: A meta-analysis
por: Chokesuwattanaskul, Ronpichai, et al.
Publicado: (2018)

Stroke-independent contribution of atrial fibrillation to dementia: a meta-analysis
por: Saglietto, Andrea, et al.
Publicado: (2019)

Role of Endothelial Nitric Oxide Synthase Polymorphisms in Atrial Fibrillation: A PRISMA-Compliant Meta-Analysis
por: Zhang, Yi-Qing, et al.
Publicado: (2019)

A meta-analysis on Omega-3 supplements in preventing recurrence of atrial fibrillation
por: Jiang, Ying, et al.
Publicado: (2017)

The progression in atrial fibrillation patients with COPD: a systematic review and meta-analysis
por: Chen, Xiaoying, et al.
Publicado: (2017)

Predictive Value of HAS-BLED Score Regarding Bleeding Events and Graft Survival following Renal Transplantation
por: Hau, Hans Michael, et al.
Publicado: (2022)

Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
por: Li, Wei-Jia, et al.
Publicado: (2021)

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials
por: Golwala, Harsh B, et al.
Publicado: (2018)

Durability of pulmonary vein isolation for atrial fibrillation: a meta-analysis and systematic review
por: Serban, Teodor, et al.
Publicado: (2023)

Efficacy and Safety of Catheter Ablation Combined with Left Atrial Appendage Closure in the Treatment of Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Wang, An, et al.
Publicado: (2022)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients with Heart failure: A Meta-Analysis of Randomized Controlled Trials
por: Yu, Zhangjie, et al.
Publicado: (2022)

High Killips Class as a Predictor of New-onset Atrial Fibrillation Following Acute Myocardial Infarction: Systematic Review and Meta-analysis
por: Zhang, En-Yuan, et al.
Publicado: (2015)

Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis
por: Nochaiwong, Surapon, et al.
Publicado: (2016)

A meta-analysis of extended ECG monitoring in detection of atrial fibrillation in patients with cryptogenic stroke
por: Jiang, Haowen, et al.
Publicado: (2022)

Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis
por: Ezzeddine, Fatima M, et al.
Publicado: (2023)

Assessment and comparison of CHADS2, CHA2DS2-VASc, and HAS-BLED scores in patients with atrial fibrillation in Saudi Arabia
por: Al-Turaiki, Abdulrahman M., et al.
Publicado: (2016)

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project
por: Xiong, Qinmei, et al.
Publicado: (2016)

Statin Therapy Decreased the Recurrence Frequency of Atrial Fibrillation after Electrical Cardioversion: A Meta-Analysis
por: Yan, Peng, et al.
Publicado: (2014)

Impact of hyperlipidemia and atrial fibrillation on the efficacy of endovascular treatment for acute ischemic stroke: a meta-analysis
por: Zheng, Jingwei, et al.
Publicado: (2017)

Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review
por: Weymann, Alexander, et al.
Publicado: (2017)

Association of clinic and ambulatory blood pressure with new‐onset atrial fibrillation: A meta‐analysis of observational studies
por: Coccina, Francesca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5l58jhttmuhir0rdtr16fdbgob